JG
ROIV icon

Jain Global’s Roivant Sciences ROIV Stock Holding History

Jain Global’s Portfolio ROIV Stock Details ROIV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$17.2M Buy
486,186
+401,008
+471% +$11.9M 0.07% 261
2026
Q1 		$2.36M Buy
+85,178
New +$2.19M 0.01% 650
2025
Q3 		– Sell
-30,587
Closed -$345K – 1428
2025
Q2 		$345K Buy
+30,587
New +$332K ﹤0.01% 865

Other funds holding ROIV

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
QF
QVT Financial New York $1.7B AUM 173.77% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return

Jain Global's ROIV Position: Q2 2026 in Review

Jain Global increased its Roivant Sciences (ROIV) stake by 471% in Q2 2026, buying an estimated $11.9M and bringing the position to 486,186 shares worth $17.2M. The position accounts for 0.07% of the portfolio, ranked #261.

Jain Global first reported a position in ROIV in Q2 2025 and has held it in 3 quarters since. 498 funds tracked by Wall St. Rank hold ROIV as of Q2 2026.

  • Jain Global held 486,186 shares of Roivant Sciences worth $17.2M as of Q2 2026.
  • Jain Global bought 401,008 Roivant Sciences shares in Q2 2026, an estimated $11.9M.
  • Roivant Sciences made up 0.07% of Jain Global's portfolio in Q2 2026, its #261 holding.
  • Jain Global first reported a position in Roivant Sciences in Q2 2025 and has held it in 3 quarters since.
  • 498 funds tracked by Wall St. Rank held Roivant Sciences as of Q2 2026.

Based on Jain Global's 13F filing for Q2 2026, filed 14 Aug 2026.